BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28365573)

  • 1. Serum Levels of Interleukin 33 and Soluble ST2 Are Associated with the Extent of Disease Activity and Cutaneous Manifestations in Patients with Active Adult-onset Still's Disease.
    Han JH; Suh CH; Jung JY; Ahn MH; Kwon JE; Yim H; Kim HA
    J Rheumatol; 2017 Jun; 44(6):740-747. PubMed ID: 28365573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Mac-2 binding protein glycosylation isomer and galectin-3 levels in adult-onset Still's disease and their association with cytokines.
    Yoshida S; Koga T; Fujita Y; Yatsuhashi H; Matsumoto H; Sumichika Y; Saito K; Sato S; Asano T; Kobayakawa M; Ohira H; Mizokami M; Sugiyama M; Migita K
    Front Immunol; 2024; 15():1385654. PubMed ID: 38711500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still's Disease From COVID-19.
    Chen PK; Lan JL; Huang PH; Hsu JL; Chang CK; Tien N; Lin HJ; Chen DY
    Front Immunol; 2021; 12():719544. PubMed ID: 34367188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report: A Rare Case of Elderly-Onset Adult-Onset Still's Disease in a Patient With Systemic Lupus Erythematosus.
    Hirooka Y; Okuda S; Sugiyama M; Shiga T; Nozaki Y; Kinoshita K; Funauchi M; Matsumura I
    Front Immunol; 2022; 13():822169. PubMed ID: 35116046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset Still's disease.
    Zhu D; Chen L; Meng J; Wang M; Ma Y; Chen X; Xiao Y; Yi D; Shi H; Sun Y; Liu H; Cheng X; Su Y; Ye J; Chi H; Zhou Z; Yang C; Teng J; Jia J; Hu Q
    J Autoimmun; 2024 Apr; 144():103182. PubMed ID: 38460457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extremely High Serum Ferritin: An Instrumental Marker of Masquerading Adult-Onset Still's Disease with Hemophagocytic Syndrome.
    Yamashita S; Furukawa NE; Matsunaga T; Hirakawa Y; Tago M; Yamashita SI
    Am J Case Rep; 2017 Dec; 18():1296-1301. PubMed ID: 29208852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased human neutrophil lipocalin and its clinical relevance in adult-onset Still's disease.
    Li J; Li Y; Li R; Ma X; Shi L; Li S; Guo Q; Jia Y; Li Z
    Chin Med J (Engl); 2023 Dec; 136(23):2867-2873. PubMed ID: 37036898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyroptosis: the potential eye of the storm in adult-onset Still's disease.
    He X; You R; Shi Y; Zeng Z; Tang B; Yu J; Xiao Y; Xiao R
    Inflammopharmacology; 2023 Oct; 31(5):2269-2282. PubMed ID: 37429997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences and similarities in cytokine profiles of macrophage activation syndrome in systemic lupus erythematosus and adult-onset Still's disease.
    Hiyama T; Kurasawa K; Hasegawa A; Miyao T; Tanaka A; Arai S; Arima M; Maezawa R
    Clin Exp Med; 2023 Nov; 23(7):3407-3416. PubMed ID: 36611087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derivation and validation of four patient clusters in Still's disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry.
    Ruscitti P; Masedu F; Vitale A; Di Cola I; Caggiano V; Di Muzio C; Cipriani P; Valenti M; Berardicurti O; Navarini L; Iacono D; Pantano I; Mauro D; Ciccia F; Rossi S; De Stefano L; Monti S; Bugatti S; Montecucco C; Caso F; Costa L; Prete M; Perosa F; Iagnocco A; Atzeni F; Guggino G; Giardini H; Antonelli IPB; Almaghlouth IA; Asfina K; Direskeneli H; Alibaz-Oner F; Sevik G; Tufan A; Sfikakis PP; La Torre F; Hinojosa-Azaola A; Martín-Nares E; Torres-Ruiz J; Ragab G; Maggio MC; Makowska J; Del Giudice E; Bartoloni E; Emmi G; Govoni M; Lo Gullo A; Lopalco G; Simonini G; Fotis L; Ogunjimi B; Tharwat S; Frediani B; Maier A; Carubbi F; Dagna L; Erten S; Gidaro A; Hernández-Rodríguez J; Sfriso P; Fabiani C; Giacomelli R; Cantarini L
    RMD Open; 2023 Nov; 9(4):. PubMed ID: 37989322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibody-Mediated Depletion of IL-1RA in Still's Disease and Potential Impact of IL-1 Targeting Therapies.
    Hoffmann MC; Cavalli G; Fadle N; Cantoni E; Regitz E; Fleser O; Klemm P; Zaks M; Stöger E; Campochiaro C; Tomelleri A; Baldissera E; Bittenbring JT; Zimmer V; Pfeifer J; Fischer Y; Preuss KD; Bewarder M; Thurner B; Fuehner S; Foell D; Dagna L; Kessel C; Thurner L
    J Clin Immunol; 2024 Jan; 44(2):45. PubMed ID: 38231276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis, disease course, and prognosis of adult-onset Still's disease: an update and review.
    Wang MY; Jia JC; Yang CD; Hu QY
    Chin Med J (Engl); 2019 Dec; 132(23):2856-2864. PubMed ID: 31856058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated monocyte distribution width in patients with active adult-onset Still's disease: a novel activity indicator.
    Lin YH; Chang SH; Hsu TC; Chen PK; Lan JL; Chen DY
    Clin Exp Rheumatol; 2023 Oct; 41(10):2062-2070. PubMed ID: 37470238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal manifestations in adult-onset Still's disease: a systematic review.
    Arya PVA; Marnet E; Rondla M; Tan JW; Unnikrishnan D; Buller G
    Rheumatol Int; 2024 Jul; 44(7):1209-1218. PubMed ID: 38625385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission.
    Giacomelli R; Caporali R; Ciccia F; Colafrancesco S; Dagna L; Govoni M; Iannone F; Leccese P; Montecucco C; Pappagallo G; Pistone G; Priori R; Ruscitti P; Sfriso P; Cantarini L;
    Autoimmun Rev; 2023 Dec; 22(12):103400. PubMed ID: 37482365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cell subsets in adult-onset Still's disease: potential candidates for disease pathogenesis and immunophenotyping.
    Fang X; Ye H; Xie Y; Wei C; Liu S; Yao H; Li Z; Jia Y; Hu F
    Arthritis Res Ther; 2023 Jun; 25(1):104. PubMed ID: 37322557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine biomarker profile for the prediction of clinical phenotypes of adult-onset Still's disease using unsupervised clustering algorithm.
    Gallardo-Pizarro A; Campos-Rodríguez V; Martín-Iglesias D; Ruiz-Irastorza G
    Int J Rheum Dis; 2024 Apr; 27(4):e15143. PubMed ID: 38576108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metagenomic next-generation sequencing on bronchoalveolar lavage fluid to contribute to diagnosis of subclinical pulmonary tuberculosis with scarce sputum and negative smear in a patient mimicking adult- onset still's disease: A case report.
    Guan Y; Ma X; Sun X; Zhang H
    Diagn Microbiol Infect Dis; 2024 Mar; 108(3):116165. PubMed ID: 38176299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of interleukin-18 and interleukin-18 binding protein in K/BxN serum transfer-induced arthritis.
    Fauteux-Daniel S; Merlo Pich LM; Girard-Guyonvarc'h C; Caruso A; Rodriguez E; Gabay C
    Front Immunol; 2023; 14():1215364. PubMed ID: 37415987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Typical evanescent and atypical persistent polymorphic cutaneous rash in an adult Brazilian with Still's disease: a case report and review of the literature.
    Michailidou D; Shin J; Forde I; Gopalratnam K; Cohen P; DeGirolamo A
    Auto Immun Highlights; 2015 Dec; 6(3):39-46. PubMed ID: 26423534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.